YK090 Glucagon EIA キット使用の文献を追加しました(Reference update)

Effects of oral administration of gelatin capsules on plasma insulin and glucagon levels in dogs
Hideaki Yokoyama, Taku Masuyama, Tomio Ishida, Yusuke Suzuki, Toshiyuki Shoda, Hideyuki Kuno, Shoichiro Sugai
Fundamental Toxicological Sciences (2017) p. 9-14
(Full PDF)

Porcine skin gelatin hydrolysate as a dipeptidyl peptidase IV inhibitor improves glycemic control in streptozotocin-induced diabetic rats (Full PDF) Shih-Li Huanga,Chuan-Chuan Hung,Chia-Ling Jao,Yu-Shan Tung,Kuo-Chiang Hsu. Journal of Functional Foods. Volume 11, November 2014, Pages 235-242

Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes. Kim TH, Kim MK, Cheong YH, Chae YN, Lee Y, Ka SO, Jung IH, Shin CY, Bae EJ, Son MH. Eur J Pharmacol. 2016 Jan 15;771:65-76. doi: 10.1016/j.ejphar.2015.11.029.

High-fat diet feeding significantly attenuates anagliptin-induced regeneration of islets of Langerhans instreptozotocin-induced diabetic mice.
Shinjo T, Nakatsu Y, Iwashita M, Sano T, Sakoda H, Ishihara H, Kushiyama A, Fujishiro M, Nishimura F, Asano T.
Diabetol Metab Syndr. 2015 Jun 2;7:50. doi: 10.1186/s13098-015-0047-y. eCollection 2015.

Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes
Tomohiko Kimura, Masashi Shimoda, Hidenori Hirukawa, Seizo Okauchi, Kenji Kohara,Sumiko Hamamoto, Kazuhito Tawaramoto, Mitsuru Hashiramoto, Kohei Kaku

Molecular and Cellular Endocrinology, Volume 400, 15 January 2015, Pages 78-89

Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabeticdb/db mice through the augmentation of IRS-2 expression.
Hirukawa H, Kaneto H, Shimoda M, Kimura T, Okauchi S, Obata A, Kohara K, Hamamoto S, Tawaramoto K, Hashiramoto M, Kaku K.
Mol Cell Endocrinol. 2015 Sep 15;413:49-60. doi: 10.1016/j.mce.2015.06.010. Epub 2015 Jun 25.

Nardilysin Is Required for Maintaining Pancreatic β-Cell Function.
Nishi K, Sato Y, Ohno M, Hiraoka Y, Saijo S, Sakamoto J, Chen PM, Morita Y, Matsuda S, Iwasaki K, Sugizaki K, Harada N, Mukumoto Y,Kiyonari H, Furuyama K, Kawaguchi Y, Uemoto S, Kita T, Inagaki N, Kimura T, Nishi E.
Diabetes. 2016 Oct;65(10):3015-27. doi: 10.2337/db16-0178. Epub 2016 Jul 6.
PAGETOP